Bipolar patients can safely and successfully receive interferon-based hepatitis C antiviral treatment

European Journal of Gastroenterology and Hepatology

Volumn 24, Issue 7, 2012, Pages 811-816

  Kelly, Erin M ^a   Corace, Kimberly ^a   Emery, Joel ^a   Cooper, Curtis L ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

bipolar disorder; depression; hepatitis C; interferon

Indexed keywords

CITALOPRAM; GABAPENTIN; INTERFERON; OLANZAPINE; PEGINTERFERON; RIBAVIRIN;

ADULT; ANTIVIRAL THERAPY; ANXIETY; ARTICLE; BIPOLAR DISORDER; CLINICAL ARTICLE; COMPARATIVE STUDY; CONFUSION; CONTROLLED STUDY; DEPRESSION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HEPATITIS C; HUMAN; IRRITABILITY; LIVER BIOPSY; MALE; MANIA; MEDICAL HISTORY; MENTAL INSTABILITY; MENTAL PATIENT; MOOD DISORDER; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT SAFETY; PRIORITY JOURNAL; PSYCHOSIS; RETROSPECTIVE STUDY; SIDE EFFECT; SUICIDAL IDEATION; TREATMENT DURATION; VIRUS LOAD;

ADULT; ANTIVIRAL AGENTS; BIPOLAR DISORDER; DEPRESSION; DRUG EVALUATION; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERONS; MALE; MENTAL DISORDERS; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84862189986     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3283535c56     Document Type: Article

References (20)

1. Loftis JM, Matthews AM, Hauser P. Psychiatric and substance use disorders in individuals with hepatitis C: epidemiology and management. Drugs 2006; 66:155-174.
2. Mistler LA, Brunette MF, Marsh BJ, Vidaver RM, Luckoor R, Rosenberg SD. Hepatitis C treatment for people with severe mental illness. Psychosomatics 2006; 47:93-107.
3. Rifai MA. Hepatitis C treatment of patients with bipolar disorder: a case series. Prim Care Companion J Clin Psychiatry 2006; 8:361-366.
4. Himelhoch S, McCarthy JF, Ganoczy D, Medoff D, Kilbourne A, Goldberg R, et al. Understanding associations between serious mental illness and hepatitis C virus among veterans: a national multivariate analysis. Psychosomatics 2009; 50:30-37.
5. Liu SS, Schneekloth TD, Talwalkar JA, Kim WR, Poterucha JJ, Charlton MR, et al. Impact of depressive symptoms and their treatment on completing antiviral treatment in patients with chronic hepatitis C. J Clin Gastroenterol 2010; 44:e178-e185.
6. Altindag A, Ozbulut O, Ozen S, Ucmak H. Interferon-alpha-induced mood disorder with manic features. Gen Hosp Psychiatry 2001; 23:168-170.
7. Greenberg DB, Jonasch E, Gadd MA, Ryan BF, Everett JR, Sober AJ, et al. Adjuvant therapy of melanoma with interferon-alpha-2b is associated with mania and bipolar syndromes. Cancer 2000; 89:356-362.
8. Kanno A, Yamada M, Abe M, Okamoto Y. A case of interferon alpha-induced manic psychosis in chronic hepatitis C. Tohoku J Exp Med 1999; 187:79-82.
9. Monji A, Yoshida I, Tashiro K, Hayashi Y, Tashiro N. A case of persistent manic depressive illness induced by interferon-alfa in the treatment of chronic hepatitis C. Psychosomatics 1998; 39:562-564.
10. Onyike CU, Bonner JO, Lyketsos CG, Treisman GJ. Mania during treatment of chronic hepatitis C with pegylated interferon and ribavirin. Am J Psychiatry 2004; 161:429-435.
11. Kim YK, Na KS, Shin KH, Jung HY, Choi SH, Kim JB. Cytokine imbalance in the pathophysiology of major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31:1044-1053.
12. Yang K, Xie G, Zhang Z, Wang C, Li W, Zhou W, et al. Levels of serum interleukin (IL)-6, IL-1beta, tumour necrosis factor-alpha and leptin and their correlation in depression. Aust N Z J Psychiatry 2007; 41:266-273.
13. Yoon HK, Kim YK. The T allele of the interferon-gamma + 874A/T polymorphism is associated with bipolar disorder. Nord J Psychiatry 2011; 44:e148-e153.
14. Castera L, Zigante F, Bastie A, Buffet C, Dhumeaux D, Hardy P. Incidence of interferon alfa-induced depression in patients with chronic hepatitis C. Hepatology 2002; 35:978-979.
15. Lim C, Olson J, Zaman A, Phelps J, Ingram KD. Prevalence and impact of manic traits in depressed patients initiating interferon therapy for chronic hepatitis C infection. J Clin Gastroenterol 2010; 44:e141-e146.
16. Altshuler LL, Post RM, Leverich GS, Mikalauskas K, Rosoff A, Ackerman L. Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am J Psychiatry 1995; 152:1130-1138.
17. Kraus MR, Schafer A, Csef H, Faller H, Mork H, Scheurlen M. Compliance with therapy in patients with chronic hepatitis C: associations with psychiatric symptoms, interpersonal problems, and mode of acquisition. Dig Dis Sci 2001; 46:2060-2065.
18. McHutchison JG, Manns M, Patel K, Poynard T, Lindsay KL, Trepo C, et al. Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C. Gastroenterology 2002; 123:1061-1069.
19. Giordano C, Cooper C. The influence of race and language on chronic hepatitis C virus infection management. Eur J Gastroenterol Hepatol 2009; 21:131-136.
20. Giordano C, Druyts EF, Garber G, Cooper C. Evaluation of immigration status, race and language barriers on chronic hepatitis C virus infection management and treatment outcomes. Eur J Gastroenterol Hepatol 2009; 21:963-968.